Sinovac Biotech Ltd. NASDAQ SVA SINOVAC or the Company a leading provider of biopharmaceutical products in China announced today that its Board of Directors the Board of Directors unanimously determined that the partial tender offer the Tender Offer by Alternative Liquidity Index LP Alternative Liquidity to acquire up to 10000000 common shares of Sinovac the Shares for 0.03 per share in cash the Offer Price is NOT advisable.